Clinical Trial Update: AcrySof IQ Toric A-Code Post-Market Clinical Study [NA]

View source ↗

Summary

Post-market clinical study update for AcrySof IQ Toric A-Code in cataract patients with astigmatism; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astigmatism
• Cataract

Drugs mentioned

• AcrySof IQ Toric A-Code (AcrySof IQ Toric A-Code)

Snippet

Sponsor: Alcon Research | Conditions: Cataract, Astigmatism | NA | Status: COMPLETED | Results posted: 2020-05-12